In vitro and in vivo targeting imaging of pancreatic cancer using a Fe₃O₄@SiO₂ nanoprobe modified with anti-mesothelin antibody

References

• TanneryKMRizzoloDPancreatic cancer: practical strategies for early diagnosis and managementJAAPA20132610273224201918
   PubMedGoogle Scholar
• WolfgangCLHermanJMLaheruDARecent progress in pancreatic cancerCA Cancer J Clin201363531834823856911
   PubMed Web of Science ®Google Scholar
• ChangMCWongJMChangYTScreening and early detection of pancreatic cancer in high risk populationWorld J Gastroenterol20142092358236424605033
   PubMedGoogle Scholar
• MunirajTJamidarPAAslanianHRPancreatic cancer: a comprehensive review and updateDis Mon2013591136840224183261
   PubMed Web of Science ®Google Scholar
• KaurSBaineMJJainMSassonARBatraSKEarly diagnosis of pancreatic cancer: challenges and new developmentsBiomark Med20126559761223075238
   PubMed Web of Science ®Google Scholar
• ChenZYWangYXLinYAdvance of molecular imaging technology and targeted imaging agent in imaging and therapyBiomed Res Int2014201481932424689058
   PubMed Web of Science ®Google Scholar
• WeisslederRPittetMJImaging in the era of molecular oncologyNature2008452718758058918385732
   PubMed Web of Science ®Google Scholar
• MankoffDAPrymaDAClarkASMolecular imaging biomarkers for oncology clinical trialsJ Nucl Med201455452552824614222
   PubMed Web of Science ®Google Scholar
• ChanAPrassasIDimitromanolakisAValidation of biomarkers that complement CA19.9 in detecting early pancreatic cancerClin Cancer Res201420225787579525239611
   PubMed Web of Science ®Google Scholar
• HanadaKOkazakiAHiranoNDiagnostic strategies for early pancreatic cancerJ Gastroenterol201550214715425501287
   PubMed Web of Science ®Google Scholar
• HollingsworthMASwansonBJMucins in cancer: protection and control of the cell surfaceNat Rev Cancer200441456014681689
   PubMed Web of Science ®Google Scholar
• QuCFLiYSongYJMUC1 expression in primary and metastatic pancreatic cancer cells for in vitro treatment by (213)Bi-C595 radioimmunoconjugateBr J Cancer200491122086209315599383
   PubMed Web of Science ®Google Scholar
• AndrianifahananaMMoniauxNSchmiedBMMucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significanceClin Cancer Res20017124033404011751498
   PubMedGoogle Scholar
• ParkJYHiroshimaYLeeJYMaawyAAHoffmanRMBouvetMMUC1 selectively targets human pancreatic cancer in orthotopic nude mouse modelsPLoS One2015103e012210025815753
   PubMedGoogle Scholar
• WuSCChenYJLinYJWuTHWangYMDevelopment of a mucin4-targeting SPIO contrast agent for effective detection of pancreatic tumor cells in vitro and in vivoJ Med Chem201356229100910924147888
   PubMed Web of Science ®Google Scholar
• RenYQZhangHYSuTWangXHZhangLClinical significance of serum survivin in patients with pancreatic ductal adenocarcinomaEur Rev Med Pharmacol Sci201418203063306825392106
   PubMedGoogle Scholar
• BobustucGCPatelAThompsonMMGMT inhibition suppresses survivin expression in pancreatic cancerPancreas201544462663525875800
   PubMedGoogle Scholar
• TongMXiongFShiYIn vitro study of SPIO-labeled human pancreatic cancer cell line BxPC-3Contrast Media Mol Imaging20138210110723281282
   PubMedGoogle Scholar
• XueAXueMJacksonCSmithRCSuppression of urokinase plasminogen activator receptor inhibits proliferation and migration of pancreatic adenocarcinoma cells via regulation of ERK/p38 signalingInt J Biochem Cell Biol2009418–91731173819433314
   PubMedGoogle Scholar
• GorantlaBAsuthkarSRaoJSPatelJGondiCSSuppression of the uPAR-uPA system retards angiogenesis, invasion, and in vivo tumor development in pancreatic cancer cellsMol Cancer Res20119437738921389187
   PubMed Web of Science ®Google Scholar
• YangLMaoHCaoZMolecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticlesGastroenterology2009136515141525.e151219208341
   PubMed Web of Science ®Google Scholar
• BrackettDPostierRRaffeldMLernerMLaszikZGHassanRMesothelin is overexpressed in pancreaticobiliary adenocarcinomas but not in normal pancreas and chronic pancreatitisAm J Clin Pathol2005124683884516416732
   PubMedGoogle Scholar
• ArganiPIacobuzio-DonahueCRyuBMesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE)Clin Cancer Res20017123862386811751476
   PubMed Web of Science ®Google Scholar
• ChenSHHungWCWangPPaulCKonstantopoulosKMesothelin binding to CA125/MUC16 promotes pancreatic cancer cell motility and invasion via MMP-7 activationSci Rep20133187023694968
   PubMed Web of Science ®Google Scholar
• TangZQianMHoMThe role of mesothelin in tumor progression and targeted therapyAnticancer Agents Med Chem201313227628022721387
   PubMed Web of Science ®Google Scholar
• YamasakiSMiuraYDavydovaJVickersSMYamamotoMIntravenous genetic mesothelin vaccine based on human adenovirus 40 inhibits growth and metastasis of pancreatic cancerInt J Cancer20131331889723233329
   PubMed Web of Science ®Google Scholar
• ZhengCJiaWTangYZhaoHJiangYSunSMesothelin regulates growth and apoptosis in pancreatic cancer cells through p53-dependent and -independent signal pathwayJ Exp Clin Cancer Res2012318423034174
   PubMed Web of Science ®Google Scholar
• DengLKeXHeZA MSLN-targeted multifunctional nanoimmunoliposome for MRI and targeting therapy in pancreatic cancerInt J Nanomedicine201275053506523028227
   PubMed Web of Science ®Google Scholar
• DongALanSHuangJModifying Fe3O4-functionalized nanoparticles with N-halamine and their magnetic/antibacterial propertiesACS Appl Mater Interfaces20113114228423522008460
   PubMed Web of Science ®Google Scholar
• WahajuddinASSuperparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriersInt J Nanomedicine201273445347122848170
   PubMed Web of Science ®Google Scholar
• SinghAKHahnMAGutweinLGMulti-dye theranostic nanoparticle platform for bioimaging and cancer therapyInt J Nanomedicine201272739275022701319
   PubMed Web of Science ®Google Scholar
• DingHLZhangYXWangSXuJMXuSCLiGHFe3O4@SiO2 core/shell nanoparticles: the silica coating regulations with a single core for different core sizes and shell thicknessesChem Mater2012242345724580
   Web of Science ®Google Scholar
• Uribe MadridSIPalUKangYSKimJKwonHKimJFabrication of Fe3O4@mSiO2 core-shell composite nanoparticles for drug delivery applicationsNanoscale Res Lett20151021726034415
   PubMedGoogle Scholar
• TangYLiangSYuSEnhanced adsorption of humic acid on amine functionalized magnetic mesoporous composite microspheresColloids Surf A Physicochem Eng Asp20124066167
   Web of Science ®Google Scholar
• XingHBuWZhangSMultifunctional nanoprobes for upconversion fluorescence, MR and CT trimodal imagingBiomaterials20123341079108922061493
   PubMed Web of Science ®Google Scholar